The EMIRATES Study

Inclusion Criteria: * Aged over 18 * Both genders * Patients who are diagnosed of low-risk well-differentiated thyroid carcinoma (papillary thyroid carcinoma or follicular carcinoma) with size of 1-4cm. This is either: 1. Diagnosed pre-operatively by fine-needle aspiration cytology (FNAC) with Thy5 grade \[see appendix for the Thy classification\] or 2. Confirmed following diagnostic hemithyroidectomy * Able to communicate in spoken and written English Exclusion Criteria: * Patients who are diagnosed with thyroid cancer with adverse features (i.e. poor differentiated cytology or tall cell, columnar cell, Hurthle cell, and solid variant cytology) * Patients who are diagnosed with thyroid cancer which is multifocal, bilateral, with extrathyroidal extension, with perineural invasion or angioinvasion. * Patients who are diagnosed with thyroid cancer with clinically or radiologically involved nodes or distant metastases * Patients who are diagnosed with thyroid cancer which is of a familial disease * Patient who is either Pregnant or breast-feeding * Patient with hyper- or hypothyroidism who is a candidate for surgery * Patient who is concurrently diagnosed with any medullary, anaplastic, lymphoma, or parathyroid disease * Patients who had previous thyroidectomy for reasons other than diagnostic hemithyroidectomy for their recent cancer diagnosis. * Patients who are cognitively impaired or have a mental health condition and are therefore unable to give consent * Patient who is not able to read write and speak English